Institute of Neuroscience and Physiology, Department of Pharmacology, The Sahlgrenska Academy at the University of Gothenburg, POB 431, SE-405 30, Gothenburg, Sweden.
Psychopharmacology (Berl). 2020 Nov;237(11):3249-3257. doi: 10.1007/s00213-020-05607-8. Epub 2020 Jul 10.
Amylin receptors consist of the calcitonin receptor (CTR) and one of three receptor activity-modifying proteins (RAMPs). The identification of amylin receptors in areas processing reward, namely laterodorsal tegmental area (LDTg), ventral tegmental area (VTA), and nucleus accumbens (NAc), has attributed them a role as reward regulators. Indeed, acute activation of amylin receptors by the amylin receptor agonist salmon calcitonin (sCT) attenuates alcohol-induced behaviours in rodents.
The effects of long-term administration of sCT on alcohol-related behaviours and the molecular mechanisms underlying these processes are not yet elucidated. To fill this knowledge gap, we investigated the effects of sub-chronic sCT treatment on the locomotor stimulatory responses to alcohol in mice and the molecular pathways involved.
We assessed the behavioural effects of sub-chronic sCT treatment by means of locomotor activity experiments in mice. We used western blot to identify changes of the CTR levels and ex vivo biochemical analysis to detect changes in monoamines and their metabolites.
After discontinuation for 5 days of sCT treatment, alcohol did not induce locomotor stimulation in mice pre-treated with sCT when compared with vehicle, without altering secondary behavioural parameters of the locomotor activity experiment or the protein levels of the CTR in reward-related areas in the same set of animals. Moreover, repeated sCT treatment altered monoaminergic neurotransmission in various brain areas, including increased serotonin and decreased dopamine turnover in the VTA. Lastly, we identified a differential effect of repeated sCT and acute alcohol administration on alcohol-induced locomotion in mice, where sCT initially attenuated and later increased this alcohol response. It was further found that this treatment combination did not affect secondary behavioural parameters measured in this locomotor activity experiments.
These data suggest that sub-chronic sCT treatment differentially alters the ability of alcohol to cause locomotor stimulation, possibly through molecular mechanisms involving various neurotransmitter systems and not the CTR levels per se.
胰岛淀粉样多肽受体由降钙素受体(CTR)和三种受体活性修饰蛋白(RAMPs)之一组成。在处理奖赏的区域(即外侧背侧被盖区(LDTg)、腹侧被盖区(VTA)和伏隔核(NAc))中鉴定出胰岛淀粉样多肽受体,这使它们成为奖赏调节因子。事实上,胰岛淀粉样多肽受体激动剂鲑鱼降钙素(sCT)急性激活可减弱啮齿动物的酒精诱导行为。
sCT 的长期给药对与酒精相关的行为的影响及其潜在的分子机制尚不清楚。为了填补这一知识空白,我们研究了 sCT 亚慢性治疗对小鼠酒精相关行为的影响及其涉及的分子途径。
我们通过小鼠的运动活动实验评估 sCT 亚慢性治疗的行为效应。我们使用 Western blot 来确定 CTR 水平的变化,并进行体外生化分析以检测单胺及其代谢物的变化。
在停止 sCT 治疗 5 天后,与载体相比,预先用 sCT 预处理的小鼠在接触酒精时不会引起运动刺激,而不会改变运动活动实验的次要行为参数或同一组动物中与奖赏相关的区域中 CTR 的蛋白水平。此外,重复 sCT 治疗改变了各种脑区的单胺能神经传递,包括 VTA 中 5-羟色胺增加和多巴胺周转率降低。最后,我们确定了重复 sCT 和急性酒精给药对小鼠酒精诱导运动的不同影响,其中 sCT 最初减弱,然后增加了这种酒精反应。进一步发现,这种治疗组合不会影响该运动活动实验中测量的次要行为参数。
这些数据表明,sCT 的亚慢性治疗会改变酒精引起运动刺激的能力,这可能是通过涉及各种神经递质系统的分子机制而不是 CTR 水平本身来实现的。